Supplementary Figure 5: In vitro effects of LIM kinases inhibitor (LIMKi) on GSCs invasive migration and tumor cells characteristics. (A)
Cell lysates of GSC and HUVEC cells were analyzed by Western blotting and probed for LIMK1, LIMK2, cofilin, and actin as a loading control. Protein quantification revealed that the endogenous level of LIMK1 was at least 100% higher in GSCs, as compared to HUVEC cells; *** P < 0.01. In contrast, no difference was observed in LIMK2 and cofilin protein levels between GSC and HUVEC cells (n = 3). (B) Lysates of GSCs treated with DMSO (control condition) or 10 μM LIMKi were plotted for p-cofilin, cofilin and actin as a loading control. By quantifying the pcofilin/cofilin ratio we observed that LIMKi-treated cells exhibited at least 45% decrease on cofilin phosphorylation; *** P < 0.01 (n = 4). (C) LIMKi effects on cells migration tendency as measured by the number of FLP formed per sphere; *** P < 0.001 (n = 3). (D) Representative images extracted from a time series of GSC-derived spheroids seeded on top of HUVEC-based confluent monolayer. GSCs progressive unloading, disrupted HUVEC-based layer and created over time an invasion area (zone enclosed within the red line). (E) LIMKi effects on GSCs transmigration capacities on HUVEC-derived confluent monolayers; *** P < 0.01 (n = 3). All graphs are presented as means ± SD; a.u; arbitrary unit. Differences with a probability level P < 0.05 were considered significant in one-way ANOVA. Bars: (C) 50 μm; (D) 50 μm; (E) 50 μm.
